Literature DB >> 9890430

Chemokines induce migration and changes in actin polymerization in adult rat brain microglia and a human fetal microglial cell line in vitro.

A K Cross1, M N Woodroofe.   

Abstract

Microglia, the resident macrophages of the central nervous system, are the primary cells to respond to injury in the brain, both in inflammation, e.g., in multiple sclerosis, and trauma. Chemokines are potential mediators of microglial cell recruitment to sites of injury; thus, the ability of microglia to migrate in response to a number of chemokines was assessed. The chemokines monocyte chemoattractant protein 1, macrophage inflammatory protein 1alpha, macrophage inflammatory protein 1beta, RANTES (regulated upon activation normal T cell expressed and secreted), interleukin 8, and IP-10 (interferon gamma inducible protein-10), induce migration and changes in the distribution of f-actin in adult rat microglia and a human microglial cell line, CHME3, in vitro. Both cell types show a significant migration response, above control levels, to all the chemokines tested in a typical dose-dependent manner. These chemokines also induced a reorganization of the actin cytoskeleton of the cells. This study indicates that chemokines play an important role in the recruitment of microglia to areas of central nervous system inflammation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9890430     DOI: 10.1002/(SICI)1097-4547(19990101)55:1<17::AID-JNR3>3.0.CO;2-J

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  41 in total

1.  Extracellular ATP or ADP induce chemotaxis of cultured microglia through Gi/o-coupled P2Y receptors.

Authors:  S Honda; Y Sasaki; K Ohsawa; Y Imai; Y Nakamura; K Inoue; S Kohsaka
Journal:  J Neurosci       Date:  2001-03-15       Impact factor: 6.167

Review 2.  Chemokines and glial cells: a complex network in the central nervous system.

Authors:  Elena Ambrosini; Francesca Aloisi
Journal:  Neurochem Res       Date:  2004-05       Impact factor: 3.996

3.  Expression analysis of the early chemokine response 4 h after in vitro traumatic brain injury.

Authors:  Astrid V Fahlenkamp; Mark Coburn; Michael Czaplik; Yu-Mi Ryang; Markus Kipp; Rolf Rossaint; Cordian Beyer
Journal:  Inflamm Res       Date:  2010-11-23       Impact factor: 4.575

4.  Purinergic receptors activating rapid intracellular Ca increases in microglia.

Authors:  Alan R Light; Ying Wu; Ronald W Hughen; Peter B Guthrie
Journal:  Neuron Glia Biol       Date:  2006-05

Review 5.  [The relevance of the inflammatory response in the injured brain].

Authors:  O I Schmidt; I Leinhase; E Hasenboehler; S J Morgan; P F Stahel
Journal:  Orthopade       Date:  2007-03       Impact factor: 1.087

6.  Absence of CCL2 and CCL3 Ameliorates Central Nervous System Grey Matter But Not White Matter Demyelination in the Presence of an Intact Blood-Brain Barrier.

Authors:  Katharina Janssen; Mira Rickert; Tim Clarner; Cordian Beyer; Markus Kipp
Journal:  Mol Neurobiol       Date:  2015-02-08       Impact factor: 5.590

7.  Cytokine production by a human microglial cell line: effects of beta-amyloid and alpha-melanocyte-stimulating hormone.

Authors:  Catharina Lindberg; Erik Hjorth; Claes Post; Bengt Winblad; Marianne Schultzberg
Journal:  Neurotox Res       Date:  2005-11       Impact factor: 3.911

Review 8.  Neuronal chemokines: versatile messengers in central nervous system cell interaction.

Authors:  A H de Haas; H R J van Weering; E K de Jong; H W G M Boddeke; K P H Biber
Journal:  Mol Neurobiol       Date:  2007-07-10       Impact factor: 5.590

9.  HIV-1 tat protein induces a migratory phenotype in human fetal microglia by a CCL2 (MCP-1)-dependent mechanism: possible role in NeuroAIDS.

Authors:  Eliseo A Eugenin; Gawain Dyer; Tina M Calderon; Joan W Berman
Journal:  Glia       Date:  2005-03       Impact factor: 7.452

10.  APOE genotype-dependent modulation of astrocyte chemokine CCL3 production.

Authors:  Eiron Cudaback; Yue Yang; Thomas J Montine; C Dirk Keene
Journal:  Glia       Date:  2014-08-04       Impact factor: 7.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.